glp-1 medical weight loss daytona beach 1 Semaglutide in ☀️ Get Summer Ready with

Substantial invested capital will be necessary to understand whether these novel targets and modalities will be successful in treating obesity

Ozempic exclusively targets GLP-1 receptors

Beyond that, a head-to-head comparison from the SURMOUNT-5 trial illustrates the difference clearly: Participants taking tirzepatide lost an average of 20.2% of their body weight compared to 13.7% with semaglutide

FAQ Q: Does GLP-1 cause depression

Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP

A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society explicitly states that restrictive eating disorder is a general contraindication to GLP-1 use and that individuals with a history of eating disorders should be referred to an eating disorders specialist before these medications are prescribed ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )